This MedLibrary.org supplementary page on Rizatriptan is provided directly from the open source Wikipedia as a service to our readers. Please see the note below on authorship of this content, as well as the Wikipedia usage guidelines. To search for other content from our encyclopedia supplement, please use the form below:
Related Sponsors
|
Rizatriptan
|
|
| Systematic (IUPAC) name | |
| N,N-dimethyl-2- [5-(1,2,4-triazol-1-ylmethyl)- 1H-indol-3-yl]ethanamine | |
| Identifiers | |
| CAS number | |
| ATC code | N02 |
| PubChem | |
| DrugBank | |
| Chemical data | |
| Formula | C15H19N5 |
| Mol. mass | 269.345 g/mol |
| Pharmacokinetic data | |
| Bioavailability | 45% |
| Protein binding | 14% |
| Metabolism | by monoamine oxidase |
| Half life | 2–3 hours |
| Excretion | 82% urine; 12% faeces |
| Therapeutic considerations | |
| Pregnancy cat. |
C |
| Legal status | |
| Routes | Oral |
Rizatriptan (Maxalt) is a 5-HT1 agonist triptan drug developed by Merck & Co. for the treatment of migraine headaches. It is available in strengths of 5 and 10 mg as tablets and orally disintegrating tablets (Maxalt-MLT).
Maxalt obtained approval by the United States Food and Drug Administration (FDA) on June 29, 1998. It is a second-generation triptan.
Rizatriptan is available only by prescription in the United States , Canada and New Zealand. Similarly, it is classed as a POM (Prescription Only Medicine) in the United Kingdom, Italy (as Rizaliv) and Israel (as Rizalt).
This medication is used to treat acute migraine attacks. It does not prevent future migraine attacks.
Indicated for:
- Severe:
- coronary artery vasospasm
- transient myocardial ischemia
- myocardial infarction
- ventricular tachycardia
- ventricular fibrillation
- hypertensive crisis
- Atypical sensations:
- Ear, nose, and throat:
- tinnitus
- sensitivity to noise
- sinusitis
- allergic rhinitis
- upper respiratory inflammation
- Muscular:
- Neurological:
- Respiratory:
- Skin:
- Miscellaneous:
External links
- Maxalt Official homepage by Merck & Co.
|
||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||
|
|||||
|
||||||||||||||
Wikipedia content modification information:
- This page was last modified on 28 November 2008, at 02:15.
Wikipedia Authorship and Review
Wikipedia content provided here is not reviewed directly by MedLibrary.org. Wikipedia content is authored by an open community of volunteers and is not produced by or in any way affiliated with MedLibrary.org.
Wikipedia Usage Guidelines
This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article on "Rizatriptan".
The URL for this specific entry is:
All Wikipedia text is available under the terms of the GNU Free Documentation License. (See Copyrights for details). Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc.
